Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
With a rapidly aging population and an increasing number of older people with cognitive impairment, a multitude of social problems could arise.
Why it matters
In older Chinese adults, greater access to blue-green spaces was positively associated with cognitive competence. The relationship appeared to be mediated by population density and PM2.5 concentration.
-
ACP can be useful for person-centered dementia care.
Why it matters
This retrospective qualitative study interviewed 23 surrogates who signed advance care planning forms to forgo life-sustaining treatment for people with advanced dementia living in old age homes. It identified seven themes in the decision-making process, and found that lacking awareness of advance care planning and patients' care values can negatively affect surrogates making proxy decisions.
-
In last two decades the growing life expectancy has spiralled the prevalence of neurogenerative disorder such as Dementia among elderly population posing a significant challenge to mental health globally.
Why it matters
This study compared several machine learning models for classifying dementia and used explainability techniques to interpret their predictions, with Random Forest performing best. It is a classification study and does not treat, cure, or prevent Alzheimer's disease.
-
Why it matters
Living near more park areas, healthy food outlets, and home health services was linked to a lower risk of entering a nursing home within 2 years among people with dementia. This suggests neighborhood resources may help people with dementia stay in their own homes.
-
Overall death rates in the US have been declining in the past few decades.
Why it matters
From 1990-1994 to 2016-2020, Alzheimer's disease death rates increased nationally, and counties with higher poverty had smaller declines or larger increases across causes of death. This describes mortality trends and disparities, not any treatment or prevention.
-
Using multiple Medicare Public Use Files (PUF), including star ratings for home health quality of patient care (QoPC), home health care CAHPS survey (HHCAHPS), county-level ADRD prevalence, and Medicare FFS enrollment, we found that the median county-level number of home health agencies was 15 (IQR 8-29), star rating was 3.4 (IQR 3.1-3.7) for QoPC and 3.8 (IQR 3.5-4.0) for HHCAHPS.
Why it matters
This county-level analysis found wide variation in access to high-quality home health agencies for people with dementia. Higher dementia prevalence was only moderately correlated with the total number of home health agencies and weakly correlated with high-quality agencies.
-
31/100
= 314,472) as early OAC initiation. Median age for both cohorts was 78 years.
Why it matters
This study found that about one-third of Medicare patients with atrial fibrillation started oral anticoagulants late, and that having dementia was among the factors linked to delayed start. It is about stroke-prevention medication timing in atrial fibrillation, not about treating, curing, or preventing Alzheimer's disease.
-
Our primary outcome was self‐reported history of cognitive screening (never versus ever had screening).
Why it matters
This national poll found that 42% of older adults reported ever having cognitive screening, and that positive beliefs about screening were linked to greater likelihood of being screened. It does not address treating, curing, or preventing Alzheimer's disease.
-
Motor and cognitive performance differed across PD and control groups.
Why it matters
A virtual reality platform detected differences in motor and cognitive performance, including more time looking at a shopping list, between people with mild Parkinson's disease and controls. This concerns Parkinson's disease and does not report any treatment, cure, or prevention for Alzheimer's disease.
-
We report a case of late-onset schizophrenia that required differentiation from a dementing disorder.
Why it matters
This case report describes an 83-year-old woman with late-onset schizophrenia whose CSF showed slightly elevated total tau and slightly decreased amyloid β1-42, suggesting Alzheimer's-type changes may also have been present. As a single case, it cannot show anything about treating, curing or preventing Alzheimer's disease.
-
ADRD specialist and drug utilization is relatively low in both DS and non‐DS, with no significant R/E differences.
Why it matters
This study examined racial and ethnic differences in specialist visits and dementia drug prescriptions among Medicare beneficiaries in the Deep South versus the rest of the US. It is about access to care, not about treating, curing or preventing Alzheimer's disease.
-
This clinical trial was designed in partnership with a Medicare Advantage (MA) plan, with the goal of comparing two care management approaches for its MA policyholders age >65 living with cognitive vulnerability.
Why it matters
This describes the design and early enrollment of a trial comparing two care management approaches for Medicare Advantage members with cognitive vulnerability. It does not yet test a treatment, cure, or prevention for Alzheimer's disease.
-
The overall NH admission rate among HCBS users with ADRD was 67%, 55%, and 36% for whites, blacks, and others, respectively.
Why it matters
Among dual-eligible HCBS users with ADRD, whites had a higher nursing home admission rate than blacks and others, and a one hundred dollars increase in monthly HCBS spending was associated with a 0.3 percentage point decrease in admission rate among whites but a 0.3 percentage point increase among blacks. The study is about service use and nursing home placement, not about treating, curing, or preventing Alzheimer's disease.
-
This study founded that low gait speed was significantly associated with dementia in older adults in nursing home.
Why it matters
This cross-sectional study found that low gait speed was an independent risk factor of dementia in elderly nursing home residents. It is an observational association and provides no evidence that changing gait speed treats, cures or prevents Alzheimer's disease.
-
Some of the considerations that need to be taken into account in coming to a decision include: Disease prevalence and burden in the country The existing health-care model and system The ratio of health-care providers to patient Cost and health-care funding in the country The current and projected health-care demand and needs The perception of the population on FP s and primary care providers versus that of specialists in hospitals and The networks and strengths of the primary care model in the country.
Why it matters
This article discusses considerations for building community-based care models and argues such teams should not be seen as inferior to hospital care. It offers no findings on treating, curing, or preventing Alzheimer's disease.
-
The translated Adaptation-Coping (adjusting to change) Model provides a way for service users (people with dementia and families) to conceptualise their journey with dementia post-diagnosis, and potentially provides service providers and researchers with aims for treatment and support.
Why it matters
This paper describes the Adaptation-Coping Model as a way for people with dementia and families to conceptualise their journey with dementia post-diagnosis, and potentially provides service providers and researchers with aims for treatment and support. The findings are initial observations based on a UK pilot service.
-
The role of primary health care has been studied in several sites and the results are promising, with an emphasis on the usefulness of community support and non-pharmacological interventions 10, 11.
Why it matters
This paper discusses priority issues in women's mental health, noting that the role of primary health care has been studied with promising results emphasizing community support and non-pharmacological interventions. It also notes that normative developments adopted by most countries have not been accompanied by changes in attitudes and cultural mores, resulting in lack of implementation of laws about gender based violence.
-
Performance on the shopping task significantly differentiated patients and healthy controls for several variables and, in particular, for total time.
Why it matters
This study found that a computerized shopping task distinguished people with alcohol dependency from healthy controls, and slower completion times were linked to poorer thinking skills and everyday functioning. It suggests such tasks could help measure everyday and cognitive functioning in this group, but it does not test any treatment, cure, or prevention for Alzheimer's disease.
-
What do we know? Figure: Douglas BeckEdwards: Our research has primarily addressed the effect of hearing aid technology on “cognitive load.”
Why it matters
This discussion reports that hearing aids can reduce listening effort for speech in noise, and that processing speed and working memory relate to cognitive benefit from hearing aid technology. It does not show that hearing aids prevent or treat Alzheimer's disease.
-
Frontotemporal dementia (FTD) is one of the most common forms of dementia in persons younger than 65 years.
Why it matters
This review for primary care physicians describes frontotemporal dementia variants, their behavioral and language features, and the use of neuroimaging to distinguish FTD from other dementias. Although no cure for FTD exists, symptom management with selective serotonin reuptake inhibitors, antipsychotics, and galantamine has been shown to be beneficial.
-
31/100
The participant demonstrated 28.6% mastery of the grocery shopping task.
Why it matters
This single-participant study found that a man with HIV-associated neurocognitive disorder completed only 28.6% of a grocery shopping task, with errors in accuracy and timing. It suggests a task analysis system may help identify such errors, but it is a single case and does not test any treatment, cure, or prevention for Alzheimer's disease.
-
31/100
That word allows us to occupy the high moral ground but to no avail.
Why it matters
This opinion piece argues that geriatric medicine has potential but requires changes to incentives and disincentives in accrediting agencies and insurance programs. It calls for maximizing the potential of geriatric medicine for the benefit of all who are aging.
-
31/100
Planned transitions among settings need to be carried out with grace, redundancy of information and accountability, and patient/family involvement.
Why it matters
This commentary argues that planned transitions among care settings need grace, redundancy of information, accountability, and patient and family involvement. It states that its beliefs are mostly shaped by clinical experience and anecdotes, and calls for data on patients' and families' experiences.
-
31/100
Down syndrome, trisomy of chromosome 21, is well investigated because it is a genetic disease with characteristic mental retardation and precocious dementia of Alzheimer type.
Why it matters
This review notes that overproduction of Aβ42 due to extra copies of genes is thought to be a leading factor in early dementia in adults with Down syndrome, and that animal models may help identify relevant genes. It reports no treatment, cure or prevention for Alzheimer's disease.
-
Overall, these numbers amount to a goal of approximately 1,300 physician faculty members in clinical departments and 1,300 other faculty for all of our nation's medical schools.
Why it matters
This paper reports that there are far too few medical school faculty involved in aging or geriatrics research and teaching, with only 200–300 such faculty compared to a goal of about 1,300 physician faculty. It concludes that the number of fellows being trained for academic positions in geriatrics and gerontology needs to more than double.
From across this topic
9 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
- Shaping a knowable event or embracing a mysterious journey: A mixed methods study on palliative care clinician views on voluntary assisted dying
- Predictors of inadequate bowel preparation for colonoscopy
- Restrictions of the Mini-Mental State Examination in acute stroke
- Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms
- Association of the Big Five personality traits with cognitive decline: a 24-week multidomain intervention study
- Intracranial hypotension: clinical presentation, imaging findings, and imaging-guided therapy
- Emerging Trends in Early Dementia Diagnosis: An Analysis on Advanced Machine Learning Approaches
- Music attuned technology care via eHealth (MATCH): A proof-of-concept study for community-dwelling people living with dementia and caregivers